Your browser doesn't support javascript.
loading
Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid Tumors.
Juric, Dejan; Krop, Ian; Ramanathan, Ramesh K; Wilson, Timothy R; Ware, Joseph A; Sanabria Bohorquez, Sandra M; Savage, Heidi M; Sampath, Deepak; Salphati, Laurent; Lin, Ray S; Jin, Huan; Parmar, Hema; Hsu, Jerry Y; Von Hoff, Daniel D; Baselga, José.
Afiliación
  • Juric D; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Krop I; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Ramanathan RK; Mayo Clinic, Scottsdale, Arizona.
  • Wilson TR; Genentech, Inc., South San Francisco, California.
  • Ware JA; Genentech, Inc., South San Francisco, California.
  • Sanabria Bohorquez SM; Genentech, Inc., South San Francisco, California.
  • Savage HM; Genentech, Inc., South San Francisco, California.
  • Sampath D; Genentech, Inc., South San Francisco, California.
  • Salphati L; Genentech, Inc., South San Francisco, California.
  • Lin RS; Genentech, Inc., South San Francisco, California.
  • Jin H; Genentech, Inc., South San Francisco, California.
  • Parmar H; Genentech, Inc., South San Francisco, California.
  • Hsu JY; Genentech, Inc., South San Francisco, California.
  • Von Hoff DD; Virginia G. Piper Cancer Center Honor Health, Scottsdale, Arizona.
  • Baselga J; Memorial Sloan Kettering Cancer Center, New York, New York. baselgaj@mskcc.org.
Cancer Discov ; 7(7): 704-715, 2017 07.
Article en En | MEDLINE | ID: mdl-28331003

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oxazepinas / Inhibidores de Proteínas Quinasas / Fosfatidilinositol 3-Quinasa Clase I / Imidazoles / Neoplasias Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Discov Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oxazepinas / Inhibidores de Proteínas Quinasas / Fosfatidilinositol 3-Quinasa Clase I / Imidazoles / Neoplasias Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Discov Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos